SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 11:27 am Sale | 2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 69 1.990% | -72 (-50.82%) | Filing |
| 2022-02-14 06:15 am Purchase | 2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 141 5.100% | 0 (+0.30%) | Filing |
| 2021-03-18 12:59 pm Purchase | 2021-03-12 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 141 6.290% | 141 (New Position) | Filing |